Authorised

Product identification

Medicine name:
Nafpenzal DC (300 mg + 100 mg + 100 mg)/3 g Maść dowymieniowa
Active substance:
  • Dihydrostreptomycin sulfate
  • Nafcillin sodium monohydrate
  • Benzylpenicillin procaine
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Dihydrostreptomycin sulfate
    100.00
    milligram(s)
    /
    3.00
    gram(s)
  • Nafcillin sodium monohydrate
    100.00
    milligram(s)
    /
    3.00
    gram(s)
  • Benzylpenicillin procaine
    300.00
    milligram(s)
    /
    1.00
    milligram(s)
Pharmaceutical form:
  • Intramammary ointment
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        5
        week
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC23
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 0688
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download
Source URL: https://medicines.health.europa.eu/veterinary/600000059787